v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Net loss $ (20,848,916) $ (15,022,027)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 735
Stock-based compensation 1,358,082 2,305,849
Change in fair value of convertible promissory notes 1,153,421
Changes in operating assets and liabilities:    
Prepaid expenses and other current and non- current assets 667,288 (81,944)
Accounts payable and other current liabilities 2,848,858 474,057
Operating lease right-of-use asset and liability, net (1,989) 142
Net cash used in operating activities (14,823,256) (12,323,188)
Cash flows from financing activities:    
Proceeds from issuance of convertible promissory notes 5,714,800
Proceeds from issuance of shares of common stock and warrants 6,396,888 5,510,591
Proceeds from issuance of preferred stock 6,000,000
Proceeds from exercise of pre-funded warrants 1,908
Issuance costs (569,465) (762,703)
Net cash provided by financing activities 17,544,131 4,747,888
Net increase (decrease) in cash and cash equivalents 2,720,875 (7,575,300)
Cash and cash equivalents at beginning of period 5,786,753 13,362,053
Cash and cash equivalents at end of period 8,507,628 5,786,753
Noncash investing and financing activities    
Transaction costs in accounts payable and other current liabilities 163,333
Settlement of convertible promissory notes 6,868,221
Issuance of commitment shares [1] $ 109
[1] Retroactively restated for one-for-twenty-eight share reverse stock split effected on June 27, 2025.